Effects of the ADH3, CYP2E1, and GSTP1 genetic polymorphisms on their expressions in Caucasian lung tissue

Lung Cancer

Volumn 38, Issue 1, 2002, Pages 15-21

  Yang, Mihi ^a,b   Coles, Brian F ^b   Delongchamp, Robert ^b   Lang, Nicholas P ^c   Kadlubar, Fred F ^b  

^a Seoul National University   (South Korea)

^b NATIONAL CENTER FOR TOXICOLOGICAL RESEARCH   (United States)

^c CENTRAL ARKANSAS VETERANS HEALTHCARE SYSTEM   (United States)

Author keywords

Acetaldehyde DNA adducts; ADH3; CYP2E1; GSTP1; Lung

Indexed keywords

ALCOHOL DEHYDROGENASE; CYTOCHROME P450 2E1; GLUTATHIONE TRANSFERASE;

ADOLESCENT; ADULT; AGE; AGED; ALLELE; ARTICLE; CANCER PREVENTION; CANCER SUSCEPTIBILITY; CONTROLLED STUDY; DNA ADDUCT; ENZYME ACTIVITY; FEMALE; GENDER; GENE EXPRESSION; GENETIC POLYMORPHISM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN TISSUE; LIFESTYLE; LUNG CANCER; LUNG PARENCHYMA; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SMOKING;

ACETALDEHYDE; ADOLESCENT; ADULT; AGE FACTORS; AGED; ALCOHOL DEHYDROGENASE; BIOTRANSFORMATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; CYTOCHROME P-450 CYP2E1; DNA ADDUCTS; EUROPEAN CONTINENTAL ANCESTRY GROUP; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTATHIONE S-TRANSFERASE PI; GLUTATHIONE TRANSFERASE; HUMANS; ISOENZYMES; LIFE STYLE; LUNG; LUNG NEOPLASMS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RISK FACTORS; SEX FACTORS;

EID: 0036804075     PISSN: 01695002     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0169-5002(02)00150-2     Document Type: Article

References (21)

1. Parkin D.M., Pisani P., Ferlay J. Global cancer statistics. CA Cancer J. 49:1999;3-64.
2. Takkouche B., Gestal-Otero J.J. The epidemiology of lung cancer: review of risk factors and Spanish data. Eur. J. Epidemiol. 12:1996;341-349.
3. IARC. IARC monographs on the evaluation of the carcinogenic risk of chemicals to humans. Tobacco smoking 38, Lyon, France, IARC, 1986.
4. Choi J.H., Chung H.C., Yoo N.C., et al. Changing trends in histologic types of lung cancer during the last decade (1981-1990) in Korea: a hospital-based study. Lung Cancer. 10:1994;287-296.
5. Harty L.C., Caporaso N.E., Hayes R.B., et al. Alcohol dehydrogenase 3 genotype and risk of oral cavity and pharyngeal cancers. J. Natl. Cancer Inst. 89:1997;1698-1705.
6. Katoh T., Kaneko S., Kohshi K., et al. Genetic polymorphisms of tobacco- and alcohol-related metabolizing enzymes and oral cavity cancer. Int. J. Cancer. 83:1999;606-609.
7. Watanabe J., Hayashi S., Kawajiri K. Different regulation and expression of the human CYP2E1 gene due to the RsaI polymorphism in the 5′-flanking region. J. Biochem. (Tokyo). 116:1994;321-326.
8. 32P-postlabeling, and GC/MS detection of 4-aminobiphenyl-DNA adducts in human peripheral lung in relation to metabolic activation pathways involving pulmonary N-oxidation, conjugation, and peroxidation. Mutat. Res. 378:1997;97-112.
9. Watt K.C., Plopper C.G., Buckpitt A.R. Measurement of cytochrome P450 2E1 activity in rat tracheobronchial airways using high-performance liquid chromatography with electrochemical detection. Anal. Biochem. 248:1997;26-30.
10. Itoh S., Matsuyama T., Kamataki T. Low activity of aldehyde dehydrogenase (ALDH) in liver of Suncus murinus: possible explanation for high sensitivity to alcohol. J. Toxicol. Sci. 22:1997;111-115.
11. Coles B.F., Anderson K.E., Doerge D.R., et al. Quantitative analysis of interindividual variation of glutathione S-transferase expression in human pancreas and the ambiguity of correlating genotype with phenotype. Cancer Res. 60:2000;573-579.
12. Kawamoto T., Koga M., Murata K., et al. Effects of ALDH2, CYP1A1, and CYP2E1 genetic polymorphisms and smoking and drinking habits on toluene metabolism in humans. Toxicol. Appl. Pharmacol. 133:1995;295-304.
13. Shen Y.C., Fan J.H., Edenberg H.J., et al. Polymorphism of ADH and ALDH genes among four ethnic groups in China and effects upon the risk for alcoholism. Alcohol Clin. Exp. Res. 21:1997;1272-1277.
14. Groppi A., Begueret J., Iron A. Improved methods for genotype determination of human alcohol dehydrogenase (ADH) at ADH 2 and ADH 3 loci by using polymerase chain reaction-directed mutagenesis. Clin. Chem. 36:1990;1765-1768.
15. Coles B., Yang M., Lang N.P., et al. Expression of hGSTP1 alleles in human lung and catalytic activity of the native protein variants towards 1-chloro-2,4-dinitrobenzene, 4-vinylpyridine and (+)-anti benzo[a]pyrene-7,8-diol-9,10-oxide. Cancer Lett. 156:2000;167-175.
16. Fang J.L., Vaca C.E. Detection of DNA adducts of acetaldehyde in peripheral white blood cells of alcohol abusers. Carcinogenesis. 18:1997;627-632.
17. Persson I., Johansson I., Bergling H., et al. Genetic polymorphism of cytochrome P4502E1 in a Swedish population. Relationship to incidence of lung cancer. FEBS Lett. 22:1993;207-211.
18. Watson M.A., Stewart R.K., Smith G.B., et al. Human glutathione S-transferase P1 polymorphisms: relationship to lung tissue enzyme activity and population frequency distribution. Carcinogenesis. 19:1998;275-280.
19. Levi F. Cancer prevention: epidemiology and perspectives. Eur. J. Cancer. 35:1999;1912-1924.
20. Wu X., Shi H., Jiang H., et al. Associations between cytochrome P4502E1 genotype, mutagen sensitivity, cigarette smoking and susceptibility to lung cancer. Carcinogenesis. 18:1997;967-973.
21. Carriere V., Berthou F., Baird S., et al. Human cytochrome P450 2E1 (CYP2E1): from genotype to phenotype. Pharmacogenetics. 6:1996;203-211.